Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108473205 | 10847320 | 5 | F | 20160926 | 20150220 | 20160928 | PER | US-PFIZER INC-2015065341 | PFIZER | 63.00 | YR | M | Y | 0.00000 | 20160928 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108473205 | 10847320 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | D | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
108473205 | 10847320 | 2 | SS | LYRICA | PREGABALIN | 1 | D | 21446 | CAPSULE, HARD | ||||||||||
108473205 | 10847320 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | UNK UNK, 3X/DAY (TAKE 1/2 OR 1 TABLET (1 MG) BY ORAL ROUTE 3 TIMES PER DAY) | 0 | TABLET | TID | ||||||||
108473205 | 10847320 | 4 | C | CIALIS | TADALAFIL | 1 | Oral | UNK, DAILY (TAKE ONE-HALF TO ONE TABLET BY MOUTH DAILY) | 0 | TABLET | |||||||||
108473205 | 10847320 | 5 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | UNK (TAKE 1/2 TO 1 TABLET BY MOUTH IN THE EVENING AT SUPPERTIME) | 0 | TABLET | |||||||||
108473205 | 10847320 | 6 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, 1X/DAY (TAKE ONE TABLET BY MOUTH EVERY MORNING) | 0 | 5 | MG | TABLET | QD | ||||||
108473205 | 10847320 | 7 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | TABLET | |||||||||||
108473205 | 10847320 | 8 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | Oral | 1 DF, 4X/DAY (HYDROCODONE 7.5 MG-ACETAMINOPHEN 325 MG) | 0 | 1 | DF | TABLET | QID | ||||||
108473205 | 10847320 | 9 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 10 MG, 1X/DAY (1 TABLET AT NIGHT BEFORE BED) | 0 | 10 | MG | TABLET | QD | |||||||
108473205 | 10847320 | 10 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | UNK (15 MG TABLET 1/2 TAB BEFORE SUPPER) | 0 | TABLET | ||||||||||
108473205 | 10847320 | 11 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | TABLET | |||||||||||
108473205 | 10847320 | 12 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | TABLET | |||||||||||
108473205 | 10847320 | 13 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | TABLET | |||||||||||
108473205 | 10847320 | 14 | C | oxycodone-acetaminophen | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | UNK (OXYCODONE: 5 MG; ACETAMINOPHEN: 325 MG)(ONE OR 2 TABLETS BY MOUTH AT BEDTIME) | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
108473205 | 10847320 | 1 | Neuropathy peripheral |
108473205 | 10847320 | 2 | Fibromyalgia |
108473205 | 10847320 | 3 | Anxiety |
108473205 | 10847320 | 4 | Dysuria |
108473205 | 10847320 | 5 | Dysuria |
108473205 | 10847320 | 6 | Prostatomegaly |
108473205 | 10847320 | 7 | Dysuria |
108473205 | 10847320 | 8 | Back pain |
108473205 | 10847320 | 9 | Gastrooesophageal reflux disease |
108473205 | 10847320 | 10 | Decreased appetite |
108473205 | 10847320 | 11 | Anxiety |
108473205 | 10847320 | 12 | Insomnia |
108473205 | 10847320 | 13 | Depression |
108473205 | 10847320 | 14 | Back pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
108473205 | 10847320 | Amnesia | |
108473205 | 10847320 | Nightmare | |
108473205 | 10847320 | Pain in extremity | |
108473205 | 10847320 | Spinal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
108473205 | 10847320 | 10 | 20150511 | 0 |